Nano-based capsule-Endoscopy with Molecular Imaging and Optical biopsy


NEMO Is an European Consortium, comprised of leading European technology companies, research institutes and universities to
develop an integrated imaging–biosensing system to screen for cancer of the gastrointestinal (GI) tract. It received the approval
from the European Commission of the Sixth EU Framework Program of Research and Technological Development (“FP6 commission”)
at the end of 2006.

The project coordinator

Project coordinator is dr. Alberto Lui and to the research work will participate dr.Georg Pucker and dr.Mher Ghulinyan of the MTLab FBK leaded by dr. Pierluigi Bellutti.

The goal

The objective of the NEMO project is to increase patient compliance with currently recommended screening guidelines by developing an advanced cancer screening system that is patient-friendly, highly sensitive and specific for early detection of cancer. To achieve this NEMO will converge optical technologies with Nano-technologies, biosensing and manoeuvring technologies to create a unique PillCam capsule endoscope capable of secretion analysis and the detection of marked and deep tissue disorders. The consortium believes the combination of the image and molecular analysis to mark the tumor may provide a novel and effective medical device for mass screening for GI cancer. The NEMO Group will invest €4.7 million over the next three years, of which the European Commission will contribute €2.8 million.